November 9, 2022
October 26, 2022
Immune checkpoint inhibitors have demonstrated their efficacy in the treatment of a broad range of tumor types, establishing the drug class as an effective treatment option against cancer. China…
September 26, 2022
Epi Data Slicer
September 26, 2022
The ovarian cancer market in China is poised to experience substantial market growth over the 2021-2031 forecast period. For patients with ovarian cancer, chemotherapy regimens remain the go-to…
September 26, 2022
Epi Data Slicer